None of their 5 “S100 positive sarcomas” expressed SOX10, which led the authors to conclude that in the setting of a soft tissue neoplasm SOX10 is more specific for peripheral nerve sheath tumors than S100. Here, SOX10 is linked to soft tissue neoplasm.